NXS 2.50% 19.5¢ next science limited

reality check, page-8

  1. 6,439 Posts.
    epaka,

    Crux, in itself, is a fabulous asset.

    But to look at that fact, in isolation, is short-sighted.

    Many interested parties have passed through the data room.

    But an inherent problem with Crux lies with the fact that a potential farm-in partner may not agree with the FEED done by NXS, the long-lead items ordered etc.

    Interested parties would have their own strategies to progress the asset, and may not agree with the way NXS has gone about maturing the prospect, hence why a deal has not yet been struck...

    Cheers
 
watchlist Created with Sketch. Add NXS (ASX) to my watchlist
(20min delay)
Last
19.5¢
Change
-0.005(2.50%)
Mkt cap ! $56.97M
Open High Low Value Volume
19.5¢ 19.5¢ 19.5¢ $5.102K 26.16K

Buyers (Bids)

No. Vol. Price($)
1 74952 19.5¢
 

Sellers (Offers)

Price($) Vol. No.
20.0¢ 35987 2
View Market Depth
Last trade - 16.10pm 09/09/2024 (20 minute delay) ?
NXS (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.